Get started
Author

E P Steller

Observed names: E. P. Steller, E. Philip Steller, E.Philip Steller, Steller, E. P.
Institution: OLVG
OpenAlex ID: A5111834449
Laparotomy enhances intraperitoneal tumor growth and abrogates the antitumor effects of interleukin-2 and lymphokine-activated killer cells.
1987 · A M Eggermont, E P Steller, et al. · PubMed · 217
Fate of gamma-interferon-activated killer blood monocytes adoptively transferred into the abdominal cavity of patients with peritoneal carcinomatosis.
1987 · H C Stevenson, A M Keenan, et al. · PubMed · 47
Immunotherapy of intraperitoneal cancer with interleukin 2 and lymphokine-activated killer cells reduces tumor load and prolongs survival in murine models
1987 · Reyer T. Ottow, E.Philip Steller, et al. · Cellular Immunology · 34
The requirements for successful immunotherapy of intraperitoneal cancer using interleukin-2 and lymphokine-activated killer cells
1987 · Reyer T. Ottow, Alexander M. M. Eggermont, et al. · Cancer · 17
PDF
Local conditions in the host influence immunotherapy with interleukin-2 and LAK cells.
1988 · E P Steller, R T Ottow, et al. · PubMed · 10
Augmentation of Interleukin-2 Immunotherapeutic Effects by Lymphokine-Activated Killer Cells and Allogeneic Stimulation in Murine Tumor Cells
1987 · Alexander M. M. Eggermont, E. Philip Steller, et al. · JNCI Journal of the National Cancer Institute · 10
Inhibitory effects of alloimmune T cells on the generation of cytolytic responses of lymphokine-activated killer cells.
1987 · P H Sugarbaker, W Matthews, et al. · PubMed · 7
Enhancement and abrogation : modifications of host immune status influence IL-2 and LAK cell immunotherapy
1988 · E P Steller · RePub (Erasmus University Rotterdam) · 5
PDF
Recruitment of inflammatory cells to a tumor deposit potentiates the immunotherapeutic effects of interleukin-2
1986 · E.Philip Steller, AlexanderM.M. Eggermont, et al. · Cancer Immunology Immunotherapy · 5
Local-Regional Adoptive Immunotherapy in Experimental Peritoneal Carcinomatosis Using Lymphokine Activated Killer Cells and Interleukin-2
1988 · A. M. M. Eggermont, R. T. Ottow, et al. · Beiträge zur Onkologie/Contributions to oncology · 3
Intraperitoneal Adoptive Immunotherapy Using Lymphokine-Activated Killer Cells and Interleukin-2
1988 · A. M. M. Eggermont, E. P. Steller, et al. · Beiträge zur Onkologie/Contributions to oncology · 1
[Granulomatous mastitis: a rare cause of breast swelling].
2007 · J C Regelink, M K Bomers, et al. · PubMed
Works count: 13
Citation count: 356
H-index: 7
I10-index: 6
Year
Topic
Type